Senior insider sale
Chief Executive Officer at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$895.3K
34.50K shares
What this filing means
COLOMA JASON V plans to sell 34.50K shares of MAZE THERAPEUTICS, INC. valued at approximately $895.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/15/2026ACC: 0001969223-26-000561
DirectorOfficer· Chief Executive Officer
Since Mar 2026
34.50K
Shares to sell
$895.3K
Approx. market value
34.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Gift
NA
9/22/2021
2.59KGift
NA
9/22/2021
31.91KTotal acquired34.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/22/2021 | Gift NA | 2.59K | Gift |
9/22/2021 | Gift NA | 31.91K | Gift |
| Total | 34.50K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
34.50K
Market value
$895.3K
5/15/2026
Total
Units
34.50K
Value
$895.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/15/2026 | 34.50K | $895.3K | Nasdaq | Planned |
| Total | 34.50K | $895.3K | ||